In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.
about
Pathogenesis and treatment of oral candidosisEffects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicansReactive oxygen species-inducing antifungal agents and their activity against fungal biofilmsAntifungal lock therapyComparison of echinocandin antifungalsSusceptibility of Pneumocystis to echinocandins in suspension and biofilm culturesAnalysis of Candida albicans mutants defective in the Cdk8 module of mediator reveal links between metabolism and biofilm formationThe Extracellular Matrix of Candida albicans Biofilms Impairs Formation of Neutrophil Extracellular TrapsThe zinc cluster transcription factor Ahr1p directs Mcm1p regulation of Candida albicans adhesionCandida biofilms: an update.Real-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole.Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.In vitro damage of Candida albicans biofilms by chitosanRole of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyeneOral candidosis--clinical challenges of a biofilm disease.In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.An easy and economical in vitro method for the formation of Candida albicans biofilms under continuous conditions of flow.Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.Micafungin in the treatment of invasive candidiasis and invasive aspergillosisEffects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy.Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilmsA 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms.Systemic antifungal therapy: new options, new challenges.Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.Prostaglandin E2 from Candida albicans Stimulates the Growth of Staphylococcus aureus in Mixed Biofilms.Candida infections of medical devices.Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals.Fungal biofilm resistance.Role for cell density in antifungal drug resistance in Candida albicans biofilmsFungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm DrugsScreening the Pathogen Box for Identification of Candida albicans Biofilm InhibitorsPolymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy.From Biology to Drug Development: New Approaches to Combat the Threat of Fungal BiofilmsEmerging echinocandins for treatment of invasive fungal infections.
P2860
Q24601191-2F4B218F-7417-4C88-B3C8-EB69E1783532Q24630887-1AD14A28-00A8-4A3E-BCEB-F24F28E584BBQ26861656-0B012FF6-A953-426F-80F8-0661A7E7B4B3Q27025682-CF7A6950-60EA-4EC8-B7AB-8B22AFA7D5C6Q28273738-20B980D8-F26C-4666-B148-0D08DEE48FD1Q28477349-6EFE4C0D-26AA-4C67-9C29-F6DE4747295FQ28543481-6AAE1BC9-F9F0-4761-ADDA-99B4538B398FQ28554057-078B459E-99F4-4F5D-9377-9C3A24BC761DQ28655846-2AD8AFAA-45A8-4E2C-B4BA-465E98CA0965Q30475833-44299C58-5484-4064-8EBF-A91D05F5CA61Q30539101-3A2A871C-59FB-4639-90D7-39DA8BD3011DQ33556039-2EBCCF6F-6222-42C0-B254-9FB96D86CEA7Q33805542-0C68F512-61B8-4853-8BCF-A0F6749DB16AQ33962613-CF76961F-0BD3-4FBD-9415-590A8C3AAA7DQ34045325-6AAA88B3-DB06-42F6-AB15-C047ED6ABA92Q34202383-BBC9412E-B2F5-477A-BD48-3CC7C8388DC5Q34368983-C4E37A09-29CE-4526-9EFC-DB2472653860Q34578357-6C86A05B-7426-421C-B37E-29BF09146B57Q34775721-152088DC-41A4-4A91-B071-3D3A1CA0BECBQ34932922-CFE223DC-11A0-40F7-8775-93FB73F931CDQ35026516-7C9F6B8F-E540-4EC7-925A-773244B21205Q35065709-38A8133C-1815-4B0E-8770-9D3492622D7CQ35092764-83C8CDEA-56E6-4227-8960-B591859490A6Q35127891-CAF7DF66-2292-49AD-B7A3-831D6EE9BCCEQ35168703-3A6CF466-02DF-4931-BD84-CF09C48979F4Q35185757-007EE83B-0931-412E-91F8-F33EB90102B6Q35218859-E3C1B8C7-F044-48F3-ADF8-B4C5B6D335E7Q35260629-52B5D397-3C8B-4B05-93A4-3D1F33AC718BQ35585219-94983B64-B552-4644-994A-52B025867491Q35635952-01440139-1C5E-46C0-AEE5-54CE42F4B615Q35742511-6E7AA469-989D-450C-9927-CF26AAD831B0Q35745818-8CF5D586-5035-45E9-97AC-CCBE9F0F3183Q35758901-6B183D8E-FC26-422C-A60B-A3A291BC372BQ35821475-E8BE26F5-3FD4-474B-A776-48E0A26D3FEDQ35878982-5091EC54-7F69-424B-9EA8-80B9A468323DQ36089061-54618526-960D-48D4-95C3-91BBA3D4BA67Q36177985-9EE79FEE-7C73-43A3-89A0-E4CBAA1649D7Q36257537-D5D4D6FC-6A9B-40EC-9F7E-75F0C0819BE4Q36422270-280B18CB-512E-435C-AF04-946BFA3C421CQ36458402-849784EE-CD7A-4D03-B892-16BCB771BC9A
P2860
In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
In vitro pharmacodynamic prope ...... termined by time-kill studies.
@en
In vitro pharmacodynamic prope ...... termined by time-kill studies.
@nl
type
label
In vitro pharmacodynamic prope ...... termined by time-kill studies.
@en
In vitro pharmacodynamic prope ...... termined by time-kill studies.
@nl
prefLabel
In vitro pharmacodynamic prope ...... termined by time-kill studies.
@en
In vitro pharmacodynamic prope ...... termined by time-kill studies.
@nl
P2093
P2860
P1476
In vitro pharmacodynamic prope ...... etermined by time-kill studies
@en
P2093
Gordon Ramage
José L López-Ribot
Kacy VandeWalle
Stefano P Bachmann
P2860
P304
P356
10.1128/AAC.46.11.3634-3636.2002
P407
P577
2002-11-01T00:00:00Z